Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cortical Metrics Validation in ASD
NCT02212275Phase 3Withdrawn
- Sponsor
- Duke University
- Start
- Aug 2015
- Primary completion
- Jul 2016
- Countries
- 1
01
Overview
Phase 3, open-label trial (2 arms), sponsored by Duke University. Primary endpoints: Difference in Cortical Metric before and after acute exposure to dextromethorphan, Change in the cortical metric over 3 weeks and 1 more. Planned start Aug 2015; status: withdrawn.
Beyond the preview
Go deeper on NCT02212275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02212275.